Kim D. Blickenstaff's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 292,983 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvation Bio Inc - Ordinar... | Kim D. Blickenstaff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 292,983 | 292,983 | - | - | Stock Option (Right to Buy) | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 31.38 per share. | 20 Nov 2024 | 30,000 | 165,190 (0%) | 0% | 31.4 | 941,400 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 20 Nov 2024 | 10,000 | 195,190 (0%) | 0% | 30 | 300,000 | Common Stock |
| Nuvation Bio Inc - Ordinar... | Kim D. Blickenstaff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 200,801 | 200,801 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc - Ordinar... | Kim D. Blickenstaff | Director | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 11 Jun 2024 | 172,189 | 172,189 | - | 2.9 | 500,089 | Class A Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.73 per share. | 23 May 2024 | 4,434 | 17,848 (0%) | 0% | 51.7 | 229,371 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 4,434 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 4,387 | 4,387 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 4,434 | 4,434 | - | - | RSU 2023 05 24 | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 2,757 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 2,757 | 13,414 (0%) | 0% | 0 | Common Stock | |
| Nuvation Bio Inc - Ordinar... | Kim D. Blickenstaff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 366,744 | 366,744 | - | - | Stock Option (Right to Buy) | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2022 | 13,562 | 0 | - | - | Warrant | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 17 May 2022 | 13,562 | 215,952 (0%) | 0% | 73.7 | 999,872 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 92.91 per share. | 17 May 2022 | 10,762 | 205,190 (0%) | 0% | 92.9 | 999,897 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.00 per share. | 17 May 2022 | 6,560 | 8,452 (0%) | 0% | 9 | 59,040 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2022 | 6,560 | 0 | - | - | Stock Option | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2022 | 2,205 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2022 | 2,205 | 10,657 (0%) | 0% | 0 | Common Stock | |
| Nuvation Bio Inc - Ordinar... | Kim D. Blickenstaff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 140,713 | 140,713 | - | - | Stock Option (Right to Buy) | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 113.35 per share. | 02 Sep 2021 | 28,400 | 202,690 (0%) | 0% | 113.4 | 3,219,140 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 114.26 per share. | 02 Sep 2021 | 300 | 202,390 (0%) | 0% | 114.3 | 34,278 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2021 | 28,700 | 0 | - | - | Series A Warrants | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. | 27 Aug 2021 | 28,700 | 231,090 (0%) | 0% | 3.5 | 100,450 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 109.07 per share. | 16 Aug 2021 | 24,240 | 228,150 (0%) | 0% | 109.1 | 2,643,852 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 109.12 per share. | 16 Aug 2021 | 19,250 | 202,390 (0%) | 0% | 109.1 | 2,100,654 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 108.09 per share. | 16 Aug 2021 | 6,510 | 221,640 (0%) | 0% | 108.1 | 703,644 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 107.20 per share. | 12 Aug 2021 | 50,000 | 252,390 (0%) | 0% | 107.2 | 5,359,825 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 105.50 per share. | 12 Aug 2021 | 13,990 | 302,390 (0%) | 0% | 105.5 | 1,475,934 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 107.21 per share. | 10 Aug 2021 | 3,210 | 316,380 (0%) | 0% | 107.2 | 344,134 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 107.64 per share. | 06 Aug 2021 | 60,761 | 338,829 (0%) | 0% | 107.6 | 6,540,393 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 107.64 per share. | 06 Aug 2021 | 19,239 | 319,590 (0%) | 0% | 107.6 | 2,070,911 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 109.39 per share. | 06 Aug 2021 | 2,800 | 399,590 (0%) | 0% | 109.4 | 306,303 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 88.66 per share. | 08 Jun 2021 | 18,077 | 417,190 (0%) | 0% | 88.7 | 1,602,658 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 87.41 per share. | 08 Jun 2021 | 17,123 | 435,267 (0%) | 0% | 87.4 | 1,496,721 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 89.25 per share. | 08 Jun 2021 | 2,800 | 414,390 (0%) | 0% | 89.3 | 249,901 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 1,892 | 1,892 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 1,892 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 2,205 | 2,205 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 87.10 per share. | 15 Mar 2021 | 135,934 | 516,456 (0%) | 0% | 87.1 | 11,840,354 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 88.18 per share. | 15 Mar 2021 | 23,828 | 453,490 (0%) | 0% | 88.2 | 2,101,055 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 87.19 per share. | 15 Mar 2021 | 20,594 | 477,318 (0%) | 0% | 87.2 | 1,795,564 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 87.85 per share. | 15 Mar 2021 | 13,044 | 503,412 (0%) | 0% | 87.9 | 1,145,941 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 85.96 per share. | 15 Mar 2021 | 5,500 | 497,912 (0%) | 0% | 86.0 | 472,769 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 88.85 per share. | 15 Mar 2021 | 1,100 | 452,390 (0%) | 0% | 88.9 | 97,739 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 87.77 per share. | 15 Dec 2020 | 48,947 | 656,885 (1%) | 0% | 87.8 | 4,296,108 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 86.68 per share. | 15 Dec 2020 | 41,158 | 705,832 (1%) | 0% | 86.7 | 3,567,390 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 93.05 per share. | 15 Dec 2020 | 10,600 | 746,990 (1%) | 0% | 93.1 | 986,381 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 88.85 per share. | 15 Dec 2020 | 4,395 | 652,490 (1%) | 0% | 88.8 | 390,485 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 90.43 per share. | 15 Dec 2020 | 2,998 | 757,590 (1%) | 0% | 90.4 | 271,116 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 90.40 per share. | 15 Dec 2020 | 100 | 652,390 (1%) | 0% | 90.4 | 9,040 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 93.00 per share. | 11 Dec 2020 | 9,150 | 760,588 (1%) | 0% | 93 | 850,950 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 95.06 per share. | 08 Dec 2020 | 13,000 | 769,738 (1%) | 0% | 95.1 | 1,235,785 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Gift of securities by or to the insider at price $ 91.94 per share. | 08 Dec 2020 | 10,000 | 799,588 (1%) | 0% | 91.9 | 919,400 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Gift of securities by or to the insider at price $ 91.94 per share. | 08 Dec 2020 | 10,000 | 809,588 (1%) | 0% | 91.9 | 919,400 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Gift of securities by or to the insider at price $ 91.94 per share. | 08 Dec 2020 | 5,000 | 787,588 (1%) | 0% | 91.9 | 459,700 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Gift of securities by or to the insider at price $ 91.94 per share. | 08 Dec 2020 | 5,000 | 794,588 (1%) | 0% | 91.9 | 459,700 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Gift of securities by or to the insider at price $ 91.94 per share. | 08 Dec 2020 | 5,000 | 819,588 (1%) | 0% | 91.9 | 459,700 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 94.22 per share. | 08 Dec 2020 | 2,850 | 782,738 (1%) | 0% | 94.2 | 268,522 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Gift of securities by or to the insider at price $ 91.94 per share. | 08 Dec 2020 | 2,000 | 785,588 (1%) | 0% | 91.9 | 183,880 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Gift of securities by or to the insider at price $ 91.94 per share. | 08 Dec 2020 | 2,000 | 792,588 (1%) | 0% | 91.9 | 183,880 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 97.01 per share. | 01 Dec 2020 | 25,000 | 824,588 (1%) | 0% | 97.0 | 2,425,163 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 107.46 per share. | 12 Nov 2020 | 12,433 | 849,588 (1%) | 0% | 107.5 | 1,336,111 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 105.22 per share. | 12 Nov 2020 | 4,369 | 862,021 (1%) | 0% | 105.2 | 459,718 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 100.09 per share. | 10 Nov 2020 | 25,000 | 866,390 (1%) | 0% | 100.1 | 2,502,273 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2020 | 6,048 | 0 | - | - | Stock Option | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.06 per share. | 10 Nov 2020 | 6,048 | 891,390 (1%) | 0% | 11.1 | 66,885 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 103.49 per share. | 18 Aug 2020 | 38,250 | 885,342 (1%) | 0% | 103.5 | 3,958,309 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.50 per share. | 18 Aug 2020 | 23,685 | 923,592 (1%) | 0% | 69.5 | 1,646,108 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2020 | 23,685 | 0 | - | - | Stock Option | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2020 | 23,585 | 135,625 | - | - | Stock Option | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.50 per share. | 18 Aug 2020 | 23,585 | 899,907 (1%) | 0% | 51.5 | 1,214,628 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2020 | 11,568 | 159,210 | - | - | Stock Option | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.50 per share. | 10 Aug 2020 | 8,882 | 882,518 (1%) | 0% | 51.5 | 457,423 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 103.34 per share. | 10 Aug 2020 | 4,248 | 878,270 (1%) | 0% | 103.3 | 438,984 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 104.32 per share. | 10 Aug 2020 | 4,134 | 874,136 (1%) | 0% | 104.3 | 431,263 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.50 per share. | 10 Aug 2020 | 2,686 | 876,322 (1%) | 0% | 51.5 | 138,329 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 104.85 per share. | 10 Aug 2020 | 500 | 873,636 (1%) | 0% | 104.8 | 52,424 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 257,000 | 28,700 | - | - | Series A Warrants | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. | 06 Aug 2020 | 257,000 | 783,783 (1%) | 0% | 3.5 | 899,500 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 200,000 | 0 | - | - | Stock Option | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.86 per share. | 06 Aug 2020 | 124,335 | 915,100 (1%) | 0% | 18.9 | 2,344,958 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 105.65 per share. | 06 Aug 2020 | 121,698 | 500,600 (0%) | 0% | 105.6 | 12,856,980 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 105.86 per share. | 06 Aug 2020 | 117,897 | 827,130 (1%) | 0% | 105.9 | 12,480,058 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.86 per share. | 06 Aug 2020 | 75,665 | 864,341 (1%) | 0% | 18.9 | 1,427,042 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 39,548 | 17,923 | - | - | Stock Option | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 39,222 | 170,778 | - | - | Stock Option | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.50 per share. | 06 Aug 2020 | 29,927 | 945,027 (1%) | 0% | 51.5 | 1,541,241 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 106.94 per share. | 06 Aug 2020 | 25,108 | 802,022 (1%) | 0% | 106.9 | 2,685,170 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 24,940 | 6,560 | - | - | Stock Option | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.06 per share. | 06 Aug 2020 | 23,260 | 622,298 (1%) | 0% | 11.1 | 257,232 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 107.65 per share. | 06 Aug 2020 | 17,439 | 784,583 (1%) | 0% | 107.6 | 1,877,237 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.06 per share. | 06 Aug 2020 | 16,288 | 526,783 (0%) | 0% | 11.1 | 180,129 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.00 per share. | 06 Aug 2020 | 14,445 | 599,038 (1%) | 0% | 9 | 130,005 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 11,875 | 6,048 | - | - | Stock Option | |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.00 per share. | 06 Aug 2020 | 10,495 | 510,495 (0%) | 0% | 9 | 94,455 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.50 per share. | 06 Aug 2020 | 9,295 | 873,636 (1%) | 0% | 51.5 | 478,693 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.06 per share. | 06 Aug 2020 | 6,982 | 790,765 (1%) | 0% | 11.1 | 77,214 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.06 per share. | 06 Aug 2020 | 4,893 | 788,676 (1%) | 0% | 11.1 | 54,112 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 108.58 per share. | 06 Aug 2020 | 800 | 783,783 (1%) | 0% | 108.6 | 86,862 | Common Stock |
| Tandem Diabetes Care Inc | Kim D. Blickenstaff | Director | Sale of securities on an exchange or to another person at price $ 107.08 per share. | 06 Aug 2020 | 600 | 500,000 (0%) | 0% | 107.1 | 64,245 | Common Stock |